MPML yields 2000000.00% · PFE yields 6.20%● Live data
📍 MPML pulled ahead of the other in Year 1
Combined, MPML + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MPML + PFE for your $10,000?
MPM Technologies, Inc., through its subsidiaries, designs, engineers, supplies, and services air pollution control systems for environmental and industrial companies in the United States and internationally. The company provides air pollution control systems by utilizing wet and dry scrubbers, wet electrostatic precipitators, and venturi absorbers that control air pollution. It also involves in the development and commercialization of Skygas, a waste-to-energy process that converts solid and semi-solid wastes into a clean-burning medium BTU gas that can be used for steam production for electric power generation, as well as for downstream conversion into chemicals. The company's Skygas technology is used for the disposal and gasification of carbonaceous wastes, such as municipal solid waste, municipal sewage sludge, pulp and paper mill sludge, auto fluff, medical waste, and used tires. It has a strategic alliance with Foton Technologies, LLC to develop projects to produce power, chemicals, and liquid fuels utilizing Skygas gasification-derived syngas. The company was formerly known as Montana Precision Mining, Ltd. and changed its name to MPM Technologies, Inc. in August 1995. MPM Technologies, Inc. was founded in 1983 and is based in Spokane Valley, Washington. MPM Technologies, Inc. operates as a subsidiary of Carbon Cycle Investments, LLC.
Full MPML Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.